Tag: Brainstorm Cell Therapeutics

In last trading session, Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) saw 63331.0 shares changing hands with its beta currently measuring 0.27. Company’s recent per share price

In the last trading session, 53599.0 shares of the Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) were traded, and its beta was 0.27. Most recently the company’s